It could lower ALT and hepatic total cholesterol (TC) levels and reduce the expression of NLRP3 and related inflammatory factors by increasing antioxidant and anti-inflammatory activities in NAFLD mice (Liu Y. T. et al., 2020). The gene discussed is NLRP3; the disease is metabolic dysfunction-associated steatotic liver disease.